Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q3 2013 · 10-Q
Revenue$4.81B$4.81B−8.7% vs Q3 2012 Net Income$966.00M$966.00M−50.3% vs Q3 2012 EPS Diluted$0.61$0.61−49.6% vs Q3 2012 Gross Profit$2,417,000,000−6.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$522,000,000−85.2% Free Cash Flowderived$245,000,000−91.8% Margins · derivedGross margin50.3%+1.3 pt vs Q3 2012
Operating margin9.8%+4.0 pt vs Q3 2012
Net margin20.1%−16.8 pt vs Q3 2012
ended Sep 30, 2013 · filed Nov 7, 2013 · 38 d after period end